Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease. Trauner M, Karpen SJ, Dawson PA. Hepatology 2025 Jul 2. doi: 10.1097/HEP.0000000000001438.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Trauner M, Karpen SJ, Dawson PA. Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease. Hepatology 2025 Jul 2. doi: 10.1097/HEP.0000000000001438.
PMID: 40601300